Background and Aim: Diabetes is a multifactorial disease characterized by chronic high blood sugar and insulin resistance. In general, the global increase in the incidence of type 2 diabetes is caused by poor nutrition and inactivity. Therefore, the aim of this study was to evaluate the effect of 8 weeks of combined exercise with quinoa supplementation on fasting blood sugar, appetite and quality of life in women with type 2 diabetes.
Materials and Methods: In this study, 36 women with type 2 diabetes were divided into 3 groups: exercise+supplement (n=12), supplement (n=12) and control (n=12). The exercise+supplement and supplement group consumed 25 grams of cooked quinoa seeds for 3 days a week. The exercise+supplement group also did combined exercise for 8 weeks, 3 times a week. Exercise was performed with an intensity of 10-12 pressure perception. The Persian version of the quality-of-life questionnaire was used to measure the quality-of-life index and the appetite questionnaire was used to assess appetite. Blood samples were taken 48 hours before and after the interventions, measurements and questionnaires were completed. One Way ANOVA, LSD post hoc and paired t were used at the significance level of P≤0.05.
Results: According to the results of 8 weeks of intervention in the exercise+supplement group (P=0.001)(2.59%) and the supplement group (P=0.04)(1.54%) compared to the control group (P=0.32)(1.54%) caused a significant reduction in Fasted blood sugar. There was also a significant decrease in appetite index in the exercise+supplement group (P<0.001)(54.20%) and the supplement group (P=0.001)(60.31%) as compared to the control group (P=0.11)(7.91%). Quality of life data also showed a significant increase in this index in the exercise+supplement group (P=0.008)(5.95%) and supplement group (P=0.002)(3.80%) as compared to the control group (P=0.10)(0.99%).
Conclusion: Eight weeks of combined exercise with consumption of quinoa seeds has a positive and improving effect on fasting blood sugar index, quality of life and appetite in patients with type 2 diabetes.
